Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)

Wakamoto Pharmaceutical Revenue

In the fiscal year ending March 31, 2012, Wakamoto Pharmaceutical had annual revenue of 9.43B JPY, down -2.45%. Wakamoto Pharmaceutical had revenue of 2.25B in the quarter ending March 31, 2012, a decrease of -10.25%. That makes Wakamoto Pharmaceutical the 26,738th largest company in the world by revenue and 2,834th in Japan.

• Revenue: 9.43B
• Revenue Growth: -2.45%
• P/S Ratio: 1.06
• Revenue / Employee: 23.40M
• Employees: 403
• Market Cap: 9.99B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Prescription drugs 5.50B 58.3%
• OTC Drugs 1.95B 20.7%
• Special Contracts 1.93B 20.5%
• Others 48.70M 0.5%

Fiscal year ended Mar 31, 2012

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2012	9.43B	-237.00M	-2.45%
Mar 31, 2011	9.67B	-107.71M	-1.10%
Mar 31, 2010	9.78B	-303.57M	-3.01%
Mar 31, 2009	10.08B	-88.89M	-0.87%
Mar 31, 2008	10.17B	-158.76M	-1.54%

Data Source: S&P Global Market Intelligence Last updated: Jun 25, 2012

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error